In response to myocardial infarction (MI), the wound healing response of the left ventricle (LV) consists of overlapping inflammatory, proliferative, and maturation phases; and the cardiac fibroblast is a key cell type involved in each phase. It has recently been appreciated that early post-MI, fibroblasts transform to a pro-inflammatory phenotype and secrete cytokines and chemokines as well as matrix metalloproteinases. Later post-MI, fibroblasts are activated to anti-inflammatory and pro-reparative phenotypes and generate anti-inflammatory and pro-angiogenic factors and extracellular matrix components that form the infarct scar. Additional studies are needed to systematically examine how fibroblast activation shifts over the time frame of MI response and how modulation at different activation stages could alter wound healing and LV remodeling in distinct ways. This review will summarize current fibroblast knowledge as a foundation to discuss existing knowledge gaps.